| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Center for Neurologic Diseases, Brigham and Women’s Hospital, Boston, MA 02115
IL-23 is a heterodimeric cytokine comprising a p19 subunit associated with the IL-12/23p40 subunit. Like IL-12, IL-23 is expressed predominantly by activated dendritic cells (DCs) and phagocytic cells, and both cytokines induce IFN-
secretion by T cells. The induction of experimental autoimmune encephalitis, the animal model of multiple sclerosis (MS), occurs in mice lacking IL-12, but not in mice with targeted disruption of IL-23 or both IL-12 and IL-23. Thus, IL-23 expression in DCs may play an important role in the pathogenesis of human autoimmune diseases such as MS. We quantified the expression of IL-23 in monocyte-derived DCs in MS patients and healthy donors and found that DCs from MS patients secrete elevated amounts of IL-23 and express increased levels of IL-23p19 mRNA. Consistent with this abnormality, we found increased IL-17 production by T cells from MS patients. We then transfected monocyte-derived DCs from healthy donors with antisense oligonucleotides specific for the IL-23p19 and IL-12p35 genes and found potent suppression of gene expression and blockade of bioactive IL-23 and IL-12 production without affecting cellular viability or DCs maturation. Inhibition of IL-23 and IL-12 was associated with increased IL-10 and decreased TNF-
production. Furthermore, transfected DCs were poor allostimulators in the MLR. Our results demonstrate that an abnormal Th1 bias in DCs from MS patients related to IL-23 exists, and that antisense oligonucleotides specific to IL-23 can be used for immune modulation by targeting DC gene expression.
This article has been cited by other articles:
|
|
 |
|
  J. M. Fletcher, R. Lonergan, L. Costelloe, K. Kinsella, B. Moran, C. O'Farrelly, N. Tubridy, and K. H. G. Mills CD39+Foxp3+ Regulatory T Cells Suppress Pathogenic Th17 Cells and Are Impaired in Multiple Sclerosis J. Immunol., December 1, 2009; 183(11): 7602 - 7610. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Brucklacher-Waldert, K. Stuerner, M. Kolster, J. Wolthausen, and E. Tolosa Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis Brain, November 23, 2009; (2009) awp289v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. S. Ramgolam, Y. Sha, J. Jin, X. Zhang, and S. Markovic-Plese IFN-{beta} Inhibits Human Th17 Cell Differentiation J. Immunol., October 15, 2009; 183(8): 5418 - 5427. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. T. Gurfein, Y. Zhang, C. B. Lopez, A. T. Argaw, A. Zameer, T. M. Moran, and G. R. John IL-11 Regulates Autoimmune Demyelination J. Immunol., October 1, 2009; 183(7): 4229 - 4240. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Miossec, T. Korn, and V. K. Kuchroo Interleukin-17 and Type 17 Helper T Cells N. Engl. J. Med., August 27, 2009; 361(9): 888 - 898. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bauer, C. Brakebusch, C. Coisne, M. Sixt, H. Wekerle, B. Engelhardt, and R. Fassler {beta}1 integrins differentially control extravasation of inflammatory cell subsets into the CNS during autoimmunity PNAS, February 10, 2009; 106(6): 1920 - 1925. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Mathers, B. M. Janelsins, J. P. Rubin, O. A. Tkacheva, W. J. Shufesky, S. C. Watkins, A. E. Morelli, and A. T. Larregina Differential Capability of Human Cutaneous Dendritic Cell Subsets to Initiate Th17 Responses J. Immunol., January 15, 2009; 182(2): 921 - 933. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Murugaiyan, A. Mittal, and H. L. Weiner Increased Osteopontin Expression in Dendritic Cells Amplifies IL-17 Production by CD4+ T Cells in Experimental Autoimmune Encephalomyelitis and in Multiple Sclerosis J. Immunol., December 1, 2008; 181(11): 7480 - 7488. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T Kobayashi, S Okamoto, T Hisamatsu, N Kamada, H Chinen, R Saito, M T Kitazume, A Nakazawa, A Sugita, K Koganei, et al. IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease Gut, December 1, 2008; 57(12): 1682 - 1689. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Koyama, H. Kagamu, S. Miura, T. Hiura, T. Miyabayashi, R. Itoh, H. Kuriyama, H. Tanaka, J. Tanaka, H. Yoshizawa, et al. Reciprocal CD4+ T-Cell Balance of Effector CD62Llow CD4+ and CD62LhighCD25+ CD4+ Regulatory T Cells in Small Cell Lung Cancer Reflects Disease Stage Clin. Cancer Res., November 1, 2008; 14(21): 6770 - 6779. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Krakauer, P Sorensen, M Khademi, T Olsson, and F Sellebjerg Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-{beta} treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression Multiple Sclerosis, June 1, 2008; 14(5): 622 - 630. [Abstract] [PDF]
|
|
|
|
|
|
L. Yang, D. E. Anderson, J. Kuchroo, and D. A. Hafler Lack of TIM-3 Immunoregulation in Multiple Sclerosis J. Immunol., April 1, 2008; 180(7): 4409 - 4414. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Finotto, T. Eigenbrod, R. Karwot, I. Boross, A. Doganci, H. Ito, N. Nishimoto, K. Yoshizaki, T. Kishimoto, S. Rose-John, et al. Local blockade of IL-6R signaling induces lung CD4+ T cell apoptosis in a murine model of asthma via regulatory T cells Int. Immunol., June 1, 2007; 19(6): 685 - 693. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Butchar, M. V. S. Rajaram, L. P. Ganesan, K. V. L. Parsa, C. D. Clay, L. S. Schlesinger, and S. Tridandapani Francisella tularensis Induces IL-23 Production in Human Monocytes J. Immunol., April 1, 2007; 178(7): 4445 - 4454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Thakker, M. W. Leach, W. Kuang, S. E. Benoit, J. P. Leonard, and S. Marusic IL-23 Is Critical in the Induction but Not in the Effector Phase of Experimental Autoimmune Encephalomyelitis J. Immunol., February 15, 2007; 178(4): 2589 - 2598. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
